| For: |
Hilgard P, Kahraman A, Lehmann N, Seltmann C, Beckebaum S, Ross RS, Baba HA, Malago M, Broelsch CE, Gerken G. Cyclosporine |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i5/697.htm |
| Number | Citing Articles |
| 1 |
Roberto J. Firpi, Consuelo Soldevila-Pico, Giuseppe G. Morelli, Roniel Cabrera, Cynthia Levy, Virginia C. Clark, Amitabh Suman, Anthony Michaels, Chaoru Chen, David R. Nelson. The Use of Cyclosporine for Recurrent Hepatitis C After Liver Transplant: A Randomized Pilot Study. Digestive Diseases and Sciences 2010; 55(1) doi: 10.1007/s10620-009-0981-3
|
| 2 |
Hengli Tang. Cyclophilin Inhibitors as a Novel HCV Therapy. Viruses 2010; 2(8) doi: 10.3390/v2081621
|
| 3 |
Yu Kihara, Naoto Matsuno, Abuduxukuer Mijiti, Takeshi Nagao, Hironori Takeuchi, Sakae Unezaki, Toshihiko Hirano. Comparative Study of the Cellular Pharmacodynamics of Calcineurin Inhibitors between Patients with Chronic Renal Failure Awaiting Renal Transplantation and Cirrhosis Patients Awaiting Liver Transplantation. Cell Transplantation 2009; 18(5-6) doi: 10.1177/096368970901805-620
|
| 4 |
Alexandra Frey, Katja Piras‐Straub, Andreas Walker, Jörg Timm, Guido Gerken, Kerstin Herzer. The influence of immunosuppressants on direct‐acting antiviral therapy is dependent on the hepatitis C virus genotype. Transplant Infectious Disease 2018; 20(1) doi: 10.1111/tid.12803
|
| 5 |
Marco Antonio Olivera-Martínez, Juan F. Gallegos-Orozco. Recurrent Viral Liver Disease (Hepatitis B and C) after Liver Transplantation. Archives of Medical Research 2007; 38(6) doi: 10.1016/j.arcmed.2006.09.003
|
| 6 |
Speranta Iacob, Vito R. Cicinnati, Philip Hilgard, Razvan A. Iacob, Liana S. Gheorghe, Irinel Popescu, Andrea Frilling, Massimo Malago, Guido Gerken, Christoph E. Broelsch, Susanne Beckebaum. Predictors of Graft and Patient Survival in Hepatitis C Virus (HCV) Recipients: Model to Predict HCV Cirrhosis After Liver Transplantation. Transplantation 2007; 84(1) doi: 10.1097/01.tp.0000267916.36343.ca
|
| 7 |
G. C. Sotiropoulos, S. Beckebaum, G. Gerken. Liver and Biliary Tract Surgery. 2006; doi: 10.1007/978-3-211-49277-2_54
|
| 8 |
Stephen Frausto, Emily Lee, Hengli Tang. Cyclophilins as Modulators of Viral Replication. Viruses 2013; 5(7) doi: 10.3390/v5071684
|
| 9 |
Robert Flisiak, Anna Parfieniuk. Investigational drugs for hepatitis C. Expert Opinion on Investigational Drugs 2010; 19(1) doi: 10.1517/13543780903431034
|
| 10 |
V. R. CICINNATI, S. IACOB, C. G. KLEIN, H. A. BABA, G. C. SOTIROPOULOS, P. HILGARD, Y. ERIM, C. E. BROELSCH, G. GERKEN, S. BECKEBAUM. Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation. Alimentary Pharmacology & Therapeutics 2007; 26(2) doi: 10.1111/j.1365-2036.2007.03363.x
|
| 11 |
Harald Farnik, Christoph Sarrazin. Behandlung von Lebertransplantationspatienten mit chronischer Virushepatitis. Viszeralmedizin 2012; 28(5) doi: 10.1159/000343724
|
| 12 |
Robert C. Huebert, Kymberly D. Watt. Hepatitis C Virus and Liver Transplantation. 2014; doi: 10.1007/978-1-4614-8438-7_3
|
| 13 |
Maria Pleguezuelo, Giacomo Germani, Andrew K Burroughs. Evidence‐Based Gastroenterology and Hepatology. 2010; doi: 10.1002/9781444314403.ch42
|
| 14 |
Robert Flisiak, Jean-Maurice Dumont, Raf Crabbé. Cyclophilin inhibitors in hepatitis C viral infection. Expert Opinion on Investigational Drugs 2007; 16(9) doi: 10.1517/13543784.16.9.1345
|
| 15 |
L.J.W. van der Laan, M. Hudson, S. McPherson, P.E. Zondervan, R.C. Thomas, J. Kwekkeboom, A.S. Lindsay, A.D. Burt, G. Kazemier, H.W. Tilanus, M.F. Bassendine, H.J. Metselaar. Results of a Two-Center Study Comparing Hepatic Fibrosis Progression in HCV-positive Liver Transplant Patients Receiving Cyclosporine or Tacrolimus. Transplantation Proceedings 2010; 42(10) doi: 10.1016/j.transproceed.2010.10.013
|
| 16 |
|
| 17 |
J. Guitard, K. Sandres-Sauné, N. Kamar, D. Ribes, S. Faguer, L. Esposito, M. Lavit, F. Muscari, J.M. Péron, L. Lavayssière, D. Durand, L. Rostaing. Hepatitis C Virus Viral Load After Conversion From Tacrolimus to Cyclosporine in Liver Transplant Patients: A Pilot Study. Transplantation Proceedings 2007; 39(8) doi: 10.1016/j.transproceed.2007.08.086
|
| 18 |
Francisco Sánchez-Bueno, Maria L. Ortiz, Juan Bermejo, Manuel Miras, José A. Pons, Pablo Ramírez, Ricardo Robles, Pascual Parrilla. Prognostic factors for hepatitis C recurrence in patients undergoing orthotopic liver transplantation. Transplant Immunology 2006; 17(1) doi: 10.1016/j.trim.2006.09.029
|
| 19 |
Zhe Liu, John M. Robida, Sreedhar Chinnaswamy, Guanghui Yi, Jason M. Robotham, Heather B. Nelson, Andre Irsigler, Cheng C. Kao, Hengli Tang. Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A #. Hepatology 2009; 50(1) doi: 10.1002/hep.22987
|
| 20 |
James R. Burton, Hugo R. Rosen. Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transplantation 2006; 12(Supplement 2) doi: 10.1002/lt.20944
|